Research / HBIO / Fundamental state Inspectable configuration
State dimensions Filing 0001171843-23-005113 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
144.03% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.80% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
12.35% · OPTIONAL · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
90.72% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
57.97% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
2.77% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
10.28% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
3.83% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 16 states History building
Sep 30, 2022 0/8 normalized Level 3 Dec 31, 2022 0/8 normalized Level 3 Mar 31, 2023 0/8 normalized Level 3 Jun 30, 2023 0/8 normalized Level 3 Sep 30, 2023 0/9 normalized Level 3 Dec 31, 2023 0/9 normalized Level 3 Mar 31, 2024 0/9 normalized Level 3 Jun 30, 2024 0/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/9 normalized Level 3 Jun 30, 2025 8/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 3 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 146.97%
Current 144.03%
Delta -2.93% Capex Intensity Increased
Previous 0.75%
Current 1.80%
Delta 1.05% Cash Generation Increased
Previous 6.04%
Current 12.35%
Delta 6.31% Inventory Pressure Increased
Previous 89.61%
Current 90.72%
Delta 1.10% Margin Decreased
Previous 61.20%
Current 57.97%
Delta -3.23% Profitability Decreased
Previous 5.83%
Current 2.77%
Delta -3.07% R And D Intensity Increased
Previous 9.66%
Current 10.28%
Delta 0.62% Sbc Intensity Decreased
Previous 3.85%
Current 3.83%
Delta -0.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.